Delivery Order SPE2D021DA002-SPE2D325F329A
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,146.40 for Adacel TDAP vaccine vials (0.5 mL) on August 4, 2025. The award carries an ultimate completion date of August 7, 2025 and was issued without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,518.30 on August 11, 2025, for the supply of Adacel TDAP vaccine vials (0.5ml). This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, carries no set-aside designation and is being funded by the Defense Department's Medical Supply Chain. The award represents a specific issuance under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $1,906.16 firm fixed-price delivery order for tetanus/diphtheria vaccines on September 10, 2025, with an ultimate completion date of September 11, 2025. The contract carries no set-aside designation and represents a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $500 million through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $1,906.16 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain for tetanus/diphtheria vaccines. Awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, this delivery order was issued without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical Group's role as a critical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 27, 2025, by the Defense Logistics Agency for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract carries a ceiling value of $17,048.40 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. No set-aside designation was utilized for this award, and the place of...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $6,073.20 to DMS Pharmaceutical Group Inc. for the supply of Adacel TDAP vaccine vials (0.5ML). The award, issued on September 10, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,632.54 by the Defense Logistics Agency's Medical Supply Chain office on August 26, 2025. This delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 and valid through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency's Medical Supply Chain division on August 20, 2025. This delivery order, with an ultimate completion date of August 21, 2025, represents a single task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $55,310.55 by the Defense Logistics Agency's Medical Supply Chain division on May 2, 2025, with an ultimate completion date of May 5, 2025. This delivery order, contract number 4568189832, was issued without set-aside designation and represents a task order under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency's Medical Supply Chain division on August 4, 2025. This delivery order, which carries no set-aside designation, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F329ADelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,821.96 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. The contract calls for delivery of Adacel TDAP vaccine in 0.5mL vials to support Department of Defense healthcare facilities. This delivery order was issued without set-aside designation and carries an ultimate completion date of August 21, 2025, with performance taking place in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products, biologics, and medical consumables to support military health facilities worldwide. As a consistent supplier to the federal pharmaceutical supply chain since its SAM.gov registration in 2001, DMS Pharmaceutical Group has established itself as a critical provider of branded and generic prescription drugs, vaccines, and specialty medications to Department of Defense healthcare sites across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/18/25 |